Shawna Hawkins, REGISTERED NURSE | |
2673 Davisson Run Rd, Clarksburg, WV 26301-6838 | |
(681) 342-3200 | |
Not Available |
Full Name | Shawna Hawkins |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 2673 Davisson Run Rd, Clarksburg, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023726627 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 57401 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shawna Hawkins, REGISTERED NURSE 2673 Davisson Run Rd, Clarksburg, WV 26301-6838 Ph: () - | Shawna Hawkins, REGISTERED NURSE 2673 Davisson Run Rd, Clarksburg, WV 26301-6838 Ph: (681) 342-3200 |
News Archive
A pilot study has found that participating in a nine-week training program including elicitation of the relaxation response had a significant impact on clinical symptoms of the gastrointestinal disorders irritable bowel syndrome and inflammatory bowel disease and on the expression of genes related to inflammation and the body's response to stress.
US-Australian drug discovery company, Novogen Ltd, and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral presentation by Professor Gil Mor MD PhD of Yale Medical School to the 62nd Annual Scientific Meeting of the Society of Reproductive Investigation in San Francisco, CA.
Following on from the recent news (30th Jan 2020) of Unilever looking to sell their PG Tips and Lipton brands, Arian Bassari, Consumer Analyst at GlobalData, a leading data analytics company, offers his view on these developments.
The University of Louisville today announced that researcher Dr. Suzanne Ildstad, representing Regenerex LLC, has entered into a license and research collaboration agreement with Novartis to provide access to stem cell technology that has the potential to help transplant patients avoid taking anti-rejection medicine for life and could serve as a platform for treatment of other diseases.
PTC Therapeutics, Inc. (PTC) today announced it is expanding the development of ataluren, an investigational new drug, to a third indication with the initiation of a Phase 2a clinical trial in nonsense mutation hemophilia A (nmHA) and hemophilia B (nmHB).
› Verified 4 days ago
Cynthia Nixon, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr., Clarksburg, WV 26301 Phone: 304-623-3461 | |
Stacey Lynn Hayes, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2673 Davisson Run Rd, Clarksburg, WV 26301 Phone: 681-342-3200 | |
Melissa Spatafore, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2673 Davisson Run Rd Ste 201, Clarksburg, WV 26301 Phone: 681-342-3200 Fax: 304-622-9458 | |
Tammi Jo Jones, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2673 Davisson Run Rd, Clarksburg, WV 26301 Phone: 681-342-3200 | |
Annette Nichols, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Drive, Clarksburg, WV 26301 Phone: 304-623-3461 | |
Micheal E Coffman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6 Hospital Plz, Clarksburg, WV 26301 Phone: 304-623-5661 Fax: 304-623-2180 |